Home/Diabetes
Condition Deep-Dive

Diabetes

Type 2 diabetes develops when the body stops responding normally to insulin and the pancreas can no longer keep up1. Weight and activity are major, changeable risk factors; remission is possible for some people, mainly through substantial weight loss, as the DiRECT trial showed2.

Cardiovascular & Metabolic Evidence-Based

Last updated:

โš ๏ธ Medication safety: please read first. The nutrition and supplement approaches on this page are meant to work alongside your prescribed treatment, never to replace it. Never stop, reduce or change your diabetes medication or insulin without your prescriber's guidance. Doing so can be dangerous. Several supplements interact with diabetes medication or insulin and can push blood sugar too low, so talk to your prescriber or pharmacist before starting anything on this page.
Definition

What Is Type 2 Diabetes?

Type 2 diabetes is a chronic metabolic condition characterized by persistently elevated blood glucose due to progressive insulin resistance followed by relative insulin deficiency; the pancreas eventually cannot compensate for the body's inability to use insulin effectively.

Insulin resistance develops silently over years: the liver, muscle and fat cells stop responding to insulin's signal to take up glucose. The pancreas compensates by secreting more insulin. Eventually, beta cells exhaust themselves, insulin production declines and blood glucose rises to diabetic levels.

The gut microbiome is an active research area: differences in gut bacteria and their metabolites, such as short-chain fatty acids from fiber, are reported in type 2 diabetes, though whether they cause it is unresolved.

โš ๏ธ Prediabetes (fasting glucose 100 to 125 mg/dL or HbA1c 5.7 to 6.4%) affects about 115 million US adults, and roughly 80% do not know they have it3. Without intervention, a substantial share progress to type 2 diabetes within five years3.
The pancreas, a cell turning away insulin labeled insulin resistance, a glucose meter reading 210 mg/dL labeled high blood sugar, a foot labeled nerve damage and icons for thirst, frequent urination and fatigue

Types of Diabetes

Type 1 (Autoimmune)

Autoimmune destruction of pancreatic beta cells, complete insulin deficiency. Onset typically in youth. Requires lifelong insulin therapy. While nutrition cannot cure T1D, it profoundly affects insulin requirements and complication risk.

Type 2 (Insulin Resistance)

Progressive insulin resistance driven by diet, inactivity, obesity and chronic inflammation. Accounts for 90 to 95% of all diagnosed diabetes cases3. Remission is possible in early stages: in the DiRECT trial, published in The Lancet in 2018, 46% of participants on the weight management program achieved remission at 12 months, rising to 86% among those who lost 33 lb (15 kg) or more2.

Prediabetes & LADA

Prediabetes: elevated glucose short of the T2D threshold, the most critical intervention window. LADA (Latent Autoimmune Diabetes in Adults) is autoimmune T1D with slow onset in adults, and it is often misclassified as T2D. Testing for GAD65 antibodies distinguishes LADA from T2D.

By the Numbers

Type 2 Diabetes by the Numbers

589M
adults worldwide living with diabetes (IDF, 2025)4
115M
US adults with prediabetes, about 80% undiagnosed (CDC)3
86%
remission at 12 months among DiRECT participants losing 33 lb (15 kg) or more (46% of all program participants)2
40.1M
people in the US with diabetes in 2023, about 11 million of them adults who do not know they have it (CDC)3
90 to 95%
of people with diabetes have type 2 (CDC)1
58%
fewer new cases of type 2 diabetes in adults with raised blood sugar who joined a lifestyle program aiming for 7% weight loss (Diabetes Prevention Program)5
Signs & Symptoms

Symptoms of Type 2 Diabetes

Type 2 diabetes develops gradually; symptoms are often subtle for years, dismissed as "normal aging" or fatigue, until complications emerge.

SymptomWhat happens
Classic Glucose-Related Symptoms
Frequent Urination (Polyuria)The kidneys attempt to excrete excess glucose in urine, pulling water with it, leading to markedly increased urination, particularly at night (nocturia). A strong early signal that blood glucose is consistently elevated above the renal threshold.
Excessive Thirst (Polydipsia)The water lost through polyuria creates dehydration and chronic thirst. No amount of water fully satisfies the thirst, because the underlying cause (high blood sugar) continues to pull fluid into urine.
Increased Hunger Despite Eating (Polyphagia)Cells are starved of glucose despite high blood sugar, because insulin resistance prevents glucose uptake. The brain detects cellular starvation and signals intense hunger, driving overeating that further worsens glucose levels.
Blurred VisionHigh blood glucose causes fluid shifts in the eye lens, temporarily altering its shape and refractive index, resulting in fluctuating, blurry vision. Chronic hyperglycemia eventually damages retinal microvasculature (diabetic retinopathy), a leading cause of blindness.
Metabolic & Complication Symptoms
Fatigue & Low EnergyCellular glucose starvation from insulin resistance, combined with mitochondrial dysfunction caused by glycation and oxidative stress, creates profound, persistent fatigue unresponsive to sleep. One of the most debilitating and overlooked symptoms of T2D.
Slow Wound HealingHyperglycemia impairs immune cell function, reduces collagen synthesis and damages microcirculation, all of which slow wound healing. Diabetic foot ulcers are a direct consequence, sometimes requiring amputation in severe cases.
Numbness & Tingling (Peripheral Neuropathy)Glycation of nerve proteins and microangiopathy (damage to small blood vessels supplying nerves) cause peripheral neuropathy, starting with numbness, tingling and burning in the feet, progressing up the legs. Affects a large share of people with long-standing type 2 diabetes.
Brain Fog & Cognitive DeclineIn a meta-analysis of 11 studies, diabetes was linked to about a 36% higher risk of Alzheimer's disease, a link that weakened after accounting for a common risk gene6, and brain insulin resistance is one proposed explanation. Even modest hyperglycemia impairs hippocampal function, memory consolidation and executive processing speed.
Causes

Causes of Type 2 Diabetes

Type 2 diabetes develops when the body's cells stop responding normally to insulin and, over years, the pancreas can no longer make enough extra insulin to keep blood sugar down1. These are the established contributors; several can be changed.

CauseHow It Contributes to Type 2 DiabetesWhat Helps
Excess weightOverweight is a leading risk factor1, and in the DiRECT trial the chance of remission rose with every step of weight lost, from 7% of people losing up to 11 lb (5 kg) to 86% of those losing 33 lb (15 kg) or more2Sustained weight loss with a supervised program, and the lower-calorie, high-fiber food pattern in the diet section
Physical inactivityBeing active less than three times a week raises risk1; the Diabetes Prevention Program's lifestyle arm aimed for at least 150 minutes of activity a week5Regular activity, including the resistance training described in the treatment section
Sugary drinksIn cohort studies of 310,819 people, those drinking 1 to 2 sugar-sweetened drinks a day had a 26% higher risk of type 2 diabetes than those drinking almost none7Replacing soda, juice and sweetened coffee with water or unsweetened drinks, as the diet section advises
Prediabetes or past gestational diabetesBoth raise the risk of type 2 diabetes1; in adults with raised fasting and post-meal glucose, a lifestyle program cut new cases by 58%5Testing, and a structured program aiming for at least 7% weight loss plus regular activity
Age, family history and ethnicityRisk is higher from age 45, with a parent, brother or sister with type 2 diabetes, and in African American, Hispanic or Latino, American Indian and Alaska Native people1These cannot be changed, which makes regular HbA1c or fasting glucose testing worthwhile
Diagnosis

How Type 2 Diabetes Is Diagnosed

TestWhat it shows
At-Home Monitoring
Continuous Glucose Monitor (CGM)Continuous glucose monitors provide real-time glucose readings every 5 minutes for 14 days. CGMs reveal postprandial spikes (missed by fasting labs), dawn phenomenon (early morning rise), nocturnal lows and food-specific responses. A useful tool for personalizing a blood sugar management diet.
Home Fasting GlucoseA standard glucometer measures fasting glucose (8-⁠hour fast). Target: <100 mg/dL (5.6 mmol/L). 100 to 125 is prediabetes. A lab fasting glucose of 126 mg/dL or more on two separate occasions is diagnostic for T2D; a high home reading needs a lab test. Monitor 3x/week at minimum when implementing dietary interventions.
Clinical Laboratory Tests
HbA1c (Glycated Hemoglobin)Measures average blood glucose over the past 2 to 3 months by quantifying glycated hemoglobin. Targets: Normal <5.7%; Prediabetes 5.7 to 6.4%; T2D โ‰ฅ6.5%; Optimal management target <7.0%. A decline of 1 percentage point corresponds to roughly a 30 mg/dL reduction in average glucose8. Retest every 3 months during active intervention.
Fasting Insulin & HOMA-IRFasting insulin reveals insulin resistance before glucose becomes elevated, the earliest detectable stage. HOMA-IR = (fasting insulin ร— fasting glucose) / 405. There is no agreed cutoff; higher values suggest insulin resistance. It is not used to diagnose diabetes. Most doctors don't order this; request it specifically.
Oral Glucose Tolerance Test (OGTT)The most sensitive test for impaired glucose tolerance. Drink 75 g glucose solution; blood glucose measured at fasting, 1 hour and 2 hours. Two-hour value under 140 mg/dL (7.8 mmol/L) normal; 140 to 199 mg/dL (7.8 to 11.0 mmol/L) prediabetes (impaired glucose tolerance); 200 mg/dL (11.1 mmol/L) or more diabetes. Reveals postprandial dysfunction missed by fasting tests.
Extended Metabolic WorkupLipid panel with particle size (LDL-P, sdLDL), uric acid, liver enzymes (NAFLD common in T2D), kidney function (creatinine, eGFR, microalbuminuria), thyroid panel, RBC magnesium, vitamin D where deficiency is suspected, and inflammatory markers (hs-CRP, ferritin). These reveal downstream complications and nutritional cofactor deficiencies.
Treatment Comparison

Conventional and Holistic Treatment for Type 2 Diabetes

๐ŸŒฟ HOLISTIC
๐Ÿ’Š CONVENTIONAL
๐ŸŒฟ

Holistic / Functional Approach

Low-carb or reduced-calorie diet, meal timing, berberine, chromium, apple cider vinegar, targeted exercise

Remission Potential
46% in remission at 1 year, and 86% among those losing 33 lb (15 kg) or more (DiRECT)2. Weight loss is what drove that result. DiRECT achieved it with a formula total diet replacement of about 825 to 853 kcal/day for 3 to 5 months, structured food reintroduction and structured support to maintain weight loss, with diabetes and blood-pressure medication withdrawn at the start. It did not test the supplements listed in this column.
Key Interventions
Low-carb or ketogenic diet, time-restricted eating, berberine, apple cider vinegar, resistance training
Timeline
HbA1c is rechecked about every 3 months9; in DiRECT, remission was measured at 12 months2
Advantage
Works on insulin resistance itself; some people reach remission, with any change to medicines made by their doctor

Full Holistic Approach Includes

  • Low-carbohydrate or ketogenic diet, one of the most studied dietary approaches for type 2 diabetes, lowering glucose by reducing its primary substrate
  • Time-restricted eating / intermittent fasting (16:8 or 18:6): improves insulin sensitivity by extending the post-absorptive state and reducing total insulin exposure
  • Berberine, studied for HbA1c reduction in multiple trials, though comparative data is limited
  • Apple cider vinegar before meals: acetic acid slows gastric emptying and blunts the post-meal glucose rise; not for anyone with gastroparesis
  • Chromium picolinate, a cofactor in insulin receptor signaling, though trial results conflict
  • Resistance training 3x/week: muscle is the primary glucose disposal tissue; building muscle mass can improve insulin sensitivity
  • Gut microbiome support: small trials of probiotics and prebiotic fibers report modest effects on insulin sensitivity
  • Magnesium glycinate: depletion is common in type 2 diabetes; repletion improves fasting glucose more consistently than HbA1c
  • Ceylon cinnamon, with mixed evidence: a Cochrane review found no benefit over placebo
โš ๏ธ Critical: If on insulin or any other glucose-lowering medication, a low-carb diet or a fasting window can rapidly lower blood glucose to dangerous levels10. On an SGLT2 inhibitor, a ketogenic diet or long fasts can cause ketoacidosis even with normal blood sugar (euglycemic DKA); agree on any such diet with your prescriber. Always work with your prescriber when making significant dietary changes; medication doses will often need to be reduced as glucose improves.
Supplement Protocol

Evidence-Based Supplements for Type 2 Diabetes

None of these replaces medication; several add to its effect and can push blood sugar too low.

SupplementWhat it is forTypical rangeTimingNotes & cautions
BerberineActivates AMPK, the metabolic pathway targeted by first-line oral diabetes medication. Meta-analyses report HbA1c reductions of roughly 0.6 to 0.7 percentage points, and small head-to-head trials found it comparable to first-line medication16. The trials are mostly small and of low quality16. No long-term cardiovascular outcomes trial exists, and berberine does not appear in NICE guideline NG28.500 mg 3x/day with mealsWith each meal to reduce postprandial spikesMonitor glucose closely if combined with hypoglycemic medications, dose adjustments likely needed. Berberine inhibits CYP3A4 and P-glycoprotein, so it can raise blood levels of many prescription medicines, and it lowers blood sugar on its own. Check with your prescriber before starting it, particularly alongside glucose-lowering medication, an anticoagulant, an immunosuppressant or any drug with a narrow safe range. Not for use in pregnancy or breastfeeding.
Chromium PicolinateA cofactor in insulin receptor signaling; deficiency impairs glucose tolerance. The evidence conflicts. Meta-analyses report HbA1c reductions of roughly 0.6 to 0.7 percentage points and fasting glucose reductions between 19 and 29 mg/dL, but reviewers note the larger effects cluster in the poorer-quality studies, and at least one meta-analysis found no meaningful fasting glucose benefit17. The NIH's National Center for Complementary and Integrative Health reaches the same verdict: chromium may help glycemic control, but the research conflicts18.400 to 1,000 mcg/dayWith the largest carbohydrate-containing mealNot recommended in excess (>1,000 mcg/day) as high chromium has genotoxic potential.
Magnesium GlycinateMagnesium is a cofactor in glucose metabolism, and people with type 2 diabetes are frequently depleted, partly because high blood sugar increases urinary magnesium loss. A meta-analysis of double-blind trials found magnesium lowered fasting glucose in people with diabetes19. NCCIH's assessment is that clinical trials have not shown a clear benefit18. Fasting glucose improves more consistently than HbA1c.400 to 600 mg elemental magnesium/dayWith dinner or before bedGlycinate is usually well tolerated. Reduce or avoid in reduced kidney function, where magnesium can build up20; check with your clinician first, and see chronic kidney disease. This whole range is above the 350 mg/day upper intake level for supplemental magnesium; above that, diarrhea is common.
Alpha-Lipoic Acid (ALA)An antioxidant used for diabetic peripheral neuropathy, and approved for it in Germany. The strongest evidence is for intravenous ALA at 600 mg/day over three weeks. Oral evidence is weaker and less consistent21. Most oral guidance is extrapolated from the intravenous trials, a real limitation.600 to 1,200 mg/day (R-ALA preferred)30 minutes before meals, fasted for best absorptionCan add to glucose-lowering medicines; monitor glucose and discuss it with your clinician.
Ceylon CinnamonThe evidence conflicts. A 2012 Cochrane review found cinnamon no better than placebo for fasting glucose, insulin or HbA1c. A later meta-analysis found a fasting glucose reduction of about 24.6 mg/dL, but with a wide confidence interval and high heterogeneity; roughly 8 of 14 trials show a benefit and 6 show none22. NCCIH summarizes the trial data as conflicting18.1 to 3 g/day (as capsules or ground in food)With mealsChoose Ceylon cinnamon; cassia cinnamon contains high levels of coumarin, a hepatotoxin at these doses. Verify species on label.
Apple Cider VinegarAcetic acid slows gastric emptying and blunts the post-meal blood sugar rise. A meta-analysis of vinegar trials found a significant reduction in post-meal glucose. A 2025 GRADE-assessed review in type 2 diabetes reported a fasting glucose reduction of about 21.9 mg/dL and an HbA1c reduction of about 0.5 percentage points23. Trials are small and results vary.1 to 2 tbsp (15 to 30 mL) diluted in 8 oz (240 mL) waterBefore the two largest mealsMust be diluted to protect tooth enamel and esophagus. Contraindicated with potassium-depleting diuretics and NSAIDs at high doses. Do not use it if you have gastroparesis (delayed stomach emptying), because it slows emptying further; see the gastroparesis guide.
Gymnema sylvestreGymnemic acids blunt sweet taste and appear to reduce intestinal glucose absorption. The human evidence is weak. In one systematic review of 10 studies with 419 participants, the results were measured as before-and-after change rather than against a control group, and heterogeneity was very high24.400 to 800 mg/day (standardized to 25% gymnemic acids)Before meals containing carbohydratesWell-tolerated. May add to the effect of glucose-lowering medications and push blood sugar too low; monitor glucose.
Inositol (Myo-inositol)A cellular messenger involved in insulin signal transduction. Meta-analyses of randomized trials found myo-inositol in pregnancy reduced gestational diabetes by roughly 44% across 12 trials in 4,765 women, though a 2023 Cochrane review judged the evidence not yet sufficient to be confident25. Evidence in polycystic ovary syndrome is also stronger than in type 2 diabetes, so its relevance here is indirect.2 to 4 g/day myo-inositol (or 40:1 ratio myo:D-chiro)With meals, split dosesIts trial evidence is in pregnancy and PCOS, not type 2 diabetes. Tell your prescriber if you take glucose-lowering medicine.
Vitamin D3Vitamin D receptors on pancreatic beta cells are involved in insulin secretion, and deficiency is common in type 2 diabetes. Observational data link higher vitamin D levels to modestly lower HbA1c. In prediabetes, pooled trials found it lowered type 2 diabetes risk by 15%, and the Endocrine Society suggests it for high-risk prediabetes26; no trial shows it reverses diabetes. Dosing: the tolerable upper intake level for adults is 4,000 IU/day. The Endocrine Society's 2024 guideline suggests against supplementing above the recommended intake to prevent disease in healthy adults under 75. Intakes below 10,000 IU/day are not usually associated with toxicity in the published literature, but sustained intake above the upper limit should only be undertaken with blood testing and clinical supervision, particularly with any kidney impairment27.Do not self-prescribe; follow your clinician's guidance.With the largest fat-containing mealSome people take it with K2 (MK-⁠7, 100 to 200 mcg); its effect on arterial calcium is not established. On a blood thinner, agree on K2 with whoever manages it first.
What to Expect

What to Expect Over Time

What happens depends on how early treatment starts and how much weight is lost; this is what trials and guidelines show for adults with type 2 diabetes.

Treatment and supportive care, together
First Weeks

Diet change and glucose-lowering medication act together, so blood sugar can fall faster than expected. In DiRECT, diabetes and blood pressure medicines were withdrawn under medical supervision at the start of the low-calorie diet2; never change a dose yourself, and agree on a plan with your prescriber before a big diet change.

Months 1 to 3

After a change in treatment, HbA1c is usually rechecked about every 3 months9. Oral medicines show most of their HbA1c effect within the first 4 to 6 months28.

Months 3 to 12

In DiRECT, 46% of people on the weight management program were in remission at 12 months (against 4% on usual care), and remission tracked the weight lost2. The average HbA1c fall from an oral medicine is unlikely to exceed 1.5%28.

Long Term

At two years, 36% of people on the DiRECT program were still in remission, and remission lasted mainly in those who kept the weight off29. Once goals are met, glucose is checked at least twice a year9; many people need more treatment over time.

When to Seek Care

Call 911 if someone with low blood sugar is confused, not responding normally or unconscious. Call 911 or go to the ER for vomiting, stomach pain, deep breathing, fruity-smelling breath or confusion, which can mean ketoacidosis, including in people with type 2 diabetes who use insulin30.

📬

Get new guides in your inbox. Once a month: new condition guides and research updates, including the trials that did not work. Free, no spam, and you can unsubscribe in one click.

Sign up

Next Steps

Steady Weight Loss Can Change the Course

Type 2 diabetes is not a life sentence. With substantial weight loss and lifestyle support, significant improvement (and for some people remission) is achievable2.

Explore NAFLD โ†’ Explore Metabolic Syndrome →

References & Evidence Notes

Each numbered entry below is either a source you can follow or a note setting out what the evidence does and does not support. Both are numbered together so the markers in the text line up.

Last reviewed October 20, 2026. Diagnostic thresholds on this page follow the American Diabetes Association Standards of Care.8 Supplement entries are cross-checked against the NIH National Center for Complementary and Integrative Health18 and the Linus Pauling Institute Micronutrient Information Center.31 This page is nutrition education, not medical advice, and it does not replace your doctor.

  1. On who develops type 2 diabetes: the CDC reports that about 90% to 95% of people with diabetes have type 2, in which cells stop responding normally to insulin until the pancreas cannot keep up, and lists prediabetes, overweight, age 45 or older, a parent or sibling with type 2 diabetes, physical activity less than three times a week, past gestational diabetes and some ethnic backgrounds as risk factors, CDC, About Type 2 Diabetes. ↩
  2. Lean MEJ, Leslie WS, Barnes AC, et al. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. The Lancet. 2018;391(10120):541-⁠551. doi:10.1016/S0140-⁠6736(17)33102-⁠1. On what it found: in 306 adults with type 2 diabetes diagnosed within the previous 6 years, remission at 12 months was 46% in the intervention group against 4% in the control group, and 86% among participants who lost 33 lb (15 kg) or more. The program withdrew diabetes and blood pressure drugs and used a formula diet of 825 to 853 kcal a day for 3 to 5 months, followed by stepped food reintroduction and structured support to maintain weight loss, PubMed 29221645. ↩
  3. Centers for Disease Control and Prevention. National Diabetes Statistics Report. cdc.gov. ↩
  4. International Diabetes Federation. IDF Diabetes Atlas, 11th ed. 2025. diabetesatlas.org. ↩
  5. On preventing type 2 diabetes: in the Diabetes Prevention Program, 3,234 adults with raised fasting and post-meal glucose were followed for an average of 2.8 years; a lifestyle program aiming for at least 7% weight loss and 150 minutes of activity a week cut new cases of diabetes by 58% against placebo, and first-line oral medication cut them by 31%, PubMed 11832527. ↩
  6. On diabetes and Alzheimer's disease: a meta-analysis of 11 cohort and case-control studies in 3,393,545 people found diabetes associated with a higher risk of Alzheimer's disease, hazard ratio 1.36, with high heterogeneity; after adjustment for the APOE e4 risk gene the association was no longer statistically significant, and the authors call for caution and better prospective studies, PubMed 41852471. ↩
  7. On sugary drinks: a 2010 meta-analysis of cohort studies in 310,819 people found that those drinking 1 to 2 sugar-sweetened drinks a day had a 26% higher risk of type 2 diabetes than those drinking less than one a month, PubMed 20693348. ↩
  8. American Diabetes Association. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes. Diabetes Care. diabetesjournals.org. ↩
  9. On how often blood sugar control is checked: the American Diabetes Association's 2025 Standards of Care recommend assessing glycemic status at least twice a year, and more often, such as every 3 months, for people not meeting their goals or after a recent change in treatment, ADA Standards of Care, 2025. ↩
  10. On low blood sugar and meals: NHS guidance notes that diabetes medicines can sometimes make blood sugar go too low, commonly with insulin and also with some other diabetes medicines, and that low blood sugar is more likely when meals are missed or delayed or too little carbohydrate is eaten, NHS, low blood sugar. ↩
  11. On first-line oral medication and HbA1c: a 2012 meta-analysis of 35 trials found it alone lowered HbA1c by 1.12% against placebo, and by 0.95% when added to other oral therapy, PubMed 22275444. ↩
  12. On GLP-⁠1 receptor agonists: a 2017 mixed-treatment meta-analysis of 34 trials in 14,464 people with type 2 diabetes found that every agent lowered HbA1c against placebo, from 0.55% to 1.21% depending on the agent. The drugs as a class reduced body weight and increased gastrointestinal side effects. The newest agent in the class was not included in that analysis, PubMed 27981757. ↩
  13. On SGLT2 inhibitors and cardiovascular outcomes: a 2019 meta-analysis of three cardiovascular outcome trials in 34,322 people with type 2 diabetes found an 11% reduction in major adverse cardiovascular events, seen only in those with established atherosclerotic disease, and a 23% reduction in cardiovascular death or hospitalization for heart failure whether or not they had that history, PubMed 30424892. ↩
  14. On side effects of glucose-lowering medicines: the American Diabetes Association's 2025 Standards of Care name gastrointestinal intolerance as the principal side effect of first-line oral medication, and note an increased risk of vitamin B12 deficiency that suggests periodic B12 testing. They also note greater gastrointestinal side effects with GLP-⁠1 receptor agonists, and that insulins and sulfonylureas can promote weight gain, ADA Standards of Care, 2025. ↩
  15. On pancreatitis with GLP-⁠1 receptor agonists: US prescribing information for these medicines carries a warning that acute pancreatitis, including fatal and non-fatal hemorrhagic or necrotizing pancreatitis, has been observed in patients treated with GLP-⁠1 receptor agonists, FDA prescribing information. ↩
  16. Guo J, Chen H, Zhang X, et al. The effect of berberine on metabolic profiles in type 2 diabetic patients: a systematic review and meta-analysis of randomized controlled trials. Oxid Med Cell Longev. 2021;2021:2074610. PubMed 34956436. Across 46 trials, berberine alone or added to standard treatment lowered HbA1c by 0.73 percentage points against control. Xie W, Su F, Wang G, et al. Glucose-lowering effect of berberine on type 2 diabetes: a systematic review and meta-analysis. Front Pharmacol. 2022;13:1015045. PubMed 36467075. Across 37 trials in 3,048 patients, HbA1c fell by 0.63 percentage points. Dong H, Wang N, Zhao L, Lu F. Berberine in the treatment of type 2 diabetes mellitus: a systemic review and meta-analysis. Evid Based Complement Alternat Med. 2012;2012:591654. PubMed 23118793. In 14 randomized trials with 1,068 participants, methodological quality was generally low, and berberine did not give significantly better glucose control than oral diabetes medicines. Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism. 2008;57(5):712-⁠717. PubMed 18442638. In a 3-⁠month pilot trial in 36 adults with newly diagnosed type 2 diabetes, its glucose-lowering effect was similar to first-line medication. Berberine is not included in NICE guideline NG28. ↩
  17. Zhao F, et al. Effect of chromium supplementation on blood glucose and lipid levels in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Biol Trace Elem Res. 2022;200(2):516-⁠525. PubMed 33783683. ↩
  18. National Center for Complementary and Integrative Health (NIH). Type 2 Diabetes and Dietary Supplements: What the Science Says. nccih.nih.gov. ↩
  19. Veronese N, et al. Effect of magnesium supplementation on glucose metabolism in people with or at risk of diabetes: a systematic review and meta-analysis of double-blind randomized controlled trials. Eur J Clin Nutr. 2016;70(12):1354-⁠1359. PubMed 27530471. ↩
  20. On magnesium and the kidneys: the NIH Office of Dietary Supplements notes that the risk of magnesium toxicity increases with impaired kidney function or kidney failure, because the ability to remove excess magnesium is reduced or lost, NIH Office of Dietary Supplements, magnesium. ↩
  21. Mijnhout GS, et al. Alpha lipoic acid for symptomatic peripheral neuropathy in patients with diabetes: a meta-analysis of randomized controlled trials. Int J Endocrinol. 2012. PMC3272801. ↩
  22. Leach MJ, Kumar S. Cinnamon for diabetes mellitus. Cochrane Database Syst Rev. 2012;(9):CD007170, found no benefit over placebo. Contrast with Allen RW, et al. Cinnamon use in type 2 diabetes: an updated systematic review and meta-analysis. Ann Fam Med. 2013;11(5):452-⁠459. annfammed.org. ↩
  23. Effects of apple cider vinegar on glycemic control and insulin sensitivity in patients with type 2 diabetes: a GRADE-assessed systematic review and dose-response meta-analysis. 2025. PMC11821484. ↩
  24. Devangan S, Varghese B, Johny E, Gurram S, Adela R. The effect of Gymnema sylvestre supplementation on glycemic control in type 2 diabetes patients: a systematic review and meta-analysis. Phytother Res. 2021;35(12):6802-⁠6812. PubMed 34467577. Across 10 studies with 419 participants, it measured change against each group's own starting values rather than against a control group, and heterogeneity between studies was very high. ↩
  25. Motuhifonua SK, et al. Antenatal dietary supplementation with myo-inositol for preventing gestational diabetes. Cochrane Database Syst Rev. 2023. Cochrane Library. Contrast with the pooled randomized-trial analyses reporting significant risk reduction, e.g. PMC9318937. ↩
  26. Pittas AG, et al. Vitamin D and Risk for Type 2 Diabetes in People With Prediabetes: A Systematic Review and Meta-analysis of Individual Participant Data From 3 Randomized Clinical Trials. Ann Intern Med. 2023;176(3):355-⁠363. PubMed 36745886. Pooling the three trials in adults with prediabetes, vitamin D lowered the risk of developing type 2 diabetes by 15% (hazard ratio 0.85, 0.75 to 0.96), an absolute reduction of 3.3% over three years; no trial was significant on its own, and one of the three used a prescription form of vitamin D rather than a supplement. A larger reduction among people who reached higher blood levels was not a randomized comparison, and those levels are above the range the National Academies advise. The Endocrine Society's 2024 guideline suggests vitamin D for adults with high-risk prediabetes, alongside lifestyle change (PubMed 38828931). ↩
  27. Institute of Medicine. Dietary Reference Intakes for Calcium and Vitamin D, Tolerable Upper Intake Levels. nationalacademies.org. The Endocrine Society's 2024 guideline suggests against supplementing above the recommended intake to prevent disease in healthy adults under 75. On toxicity thresholds see Vitamin D Toxicity, StatPearls, reporting that intakes below 10,000 IU/day are not usually associated with toxicity. ↩
  28. On how quickly oral diabetes medicines lower HbA1c: a 2010 meta-analysis of 61 trials with 26,367 participants found most oral agents lowered HbA1c by 0.5 to 1.25%, with the benefit most apparent within the first 4 to 6 months and the average fall unlikely to exceed 1.5%, PubMed 20484130. ↩
  29. On whether remission lasts: at two years in the DiRECT trial, 36% of the 149 intervention participants were still in remission against 3% of controls, and 64% of participants who kept off at least 22 lb (10 kg) were in remission, PubMed 30852132. ↩
  30. On emergencies in diabetes: NHS guidance advises calling emergency services when someone with very low blood sugar is not responding normally or is unconscious, and lists stomach pain, vomiting, deep breathing, fruity-smelling breath and confusion among the symptoms of diabetic ketoacidosis, which can happen in people with type 2 diabetes who need insulin and for which it advises calling emergency services or going to an emergency department when ketone levels are high or not known, NHS, low blood sugar and NHS, diabetic ketoacidosis. ↩
  31. Linus Pauling Institute, Oregon State University. Micronutrient Information Center, a standing reference on vitamins and minerals including chromium, magnesium, vitamin D and alpha-lipoic acid. lpi.oregonstate.edu/mic. ↩